ZNF384 and acute lymphoblastic leukemia: SEM (LC50: 44 nM) and JIH5 (LC50: 3.9 nM) cells were the most sensitive to gilteritinib, consistent with the overexpression of FLT3 in KMT2A-r and ZNF384-r ALL (Fig. 1a).